First Header Logo Second Header Logo

Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer.

Yardley DA, Hart L, Waterhouse D, Whorf R, Drosick DR, Murphy P, Badarinath S, Daniel BR, Childs BH, Burris H. Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer. Breast Cancer Res Treat. 2013 Dec; 142(3):655-65.

View in: PubMed